Clinical trial
Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With…
NCT00295035 · Tel-Aviv Sourasky Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00295035 |
|---|---|
| Title | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer |
| Official title | Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer |
| Lead sponsor | Tel-Aviv Sourasky Medical Center, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colon Neoplasm |
| Intervention type | Drug |
| Interventions | CELECOXIB, CURCUMIN |
| Enrollment | 100 |
| Start date | Mar 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Feb 22, 2006 |
| Last update posted | Feb 22, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: